Expert Interview
Discussing Pfizer’s Emerging PD-1 × VEGF Bispecific Program (PF-4404) for NSCLC
Ticker(s): PFEInstitution: Mayo Clinic, Jacksonville, FL
Chief of Hematology & Oncology, and Florida Department of Health Chair of Cancer Research at Mayo Clinic.
Manages over 200 patients with NSCLC. Nationally recognized lung cancer specialist, particularly in biomarker-driven targeted therapies and immuno-oncology; leads a multidisciplinary thoracic oncology program and has held leadership roles in ASCO and IASLC.
Innovator in integrating AI and automation into cancer care delivery: deploying AI-driven predictive models and automated care pathways to improve diagnosis, treatment planning, and patient experience.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
